|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Sofie Biosciences
| | | Phone: | (310) 215-3159 | Fax: | (310) 649-5624 | Year Established: | 2008 | Main Contact: | Patrick Phelps, President & CEO | | Other Contacts: | Melissa Moore, PhD, CTO Philipp Czernin, MBA, COO Stan Berman, MBA, CFO
| | Company Description | Sofie Biosciences was established to implement a new type of drug discovery engine based on diagnostic imaging with Positron Emission Tomography (PET). The basic premise of Sofie (derived from the Greek word for “wisdom”) is that metabolomics is a critical and largely unexplored area of drug discovery and may yield some of the most important targets for cancer, inflammation (e.g. arthritis) and autoimmune diseases (Crohn’s, multiple sclerosis). Metabolomics is literally the systematic study of the unique “chemical fingerprints” that certain cellular processes leave behind. PET imaging is the perfect tool to study these processes. | |
|
|
|
|
|